Catalytic Mechanism of Human T-Cell Leukemia Virus Type 1 Protease Investigated by Combined QM/MM Molecular Dynamics Simulations

被引:1
|
作者
Petrillo, Natalie [1 ]
Dinh, Kim [1 ]
Vogt, Kimberly A. [1 ]
Ma, Shuhua [1 ]
机构
[1] Towson Univ, Jess & Mildred Fisher Coll Sci & Math, Dept Chem, Towson, MD 21252 USA
关键词
HUMAN IMMUNODEFICIENCY VIRUS-1; HTLV-1; PROTEASE; KINETIC CHARACTERIZATION; HIV-1; SUBSTRATE-SPECIFICITY; SEMIEMPIRICAL METHODS; ELUCIDATE DETAILS; INHIBITORS; OPTIMIZATION; INTEGRATION;
D O I
10.1021/acs.jcim.3c00440
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Combined quantum mechanical and molecularmechanical(QM/MM) moleculardynamics simulations were performed to investigate the catalytic mechanismof human T-cell leukemia virus type 1 (HTLV-1) protease, a retroviralaspartic protease that is a potential therapeutic target for curingHTLV-1-associated diseases. To elucidate the proteolytic cleavagemechanism, we determined the two-dimensional free energy surfacesof the HTLV-1 protease-catalyzed reactions through various possiblepathways. The free energy simulations suggest that the catalytic reactionsof the HTLV-1 protease occur in the following sequential steps: (1)a proton is transferred from the lytic water to Asp32 ', followedby the nucleophilic addition of the resulting hydroxyl to the carbonylcarbon of the scissile bond, forming a tetrahedral oxyanion intermediate,and (2) a proton is transferred from Asp32 to the peptide nitrogenof the scissile bond, leading to the spontaneous breakage of the scissilebond. The rate-limiting step of this catalytic process is the protontransfer from Asp32 to the peptide nitrogen of the scissile bond,with a free energy of activation of 21.1 kcal/mol. This free energybarrier is close to the experimentally determined free energy of activation(16.3 kcal/mol) calculated from the measured catalytic rate constant(k (cat)). This mechanistic study providesdetailed dynamic and structural information that will facilitate thedesign of mechanism-based inhibitors for the treatment of HTLV-1-associateddiseases.
引用
收藏
页码:3865 / 3877
页数:13
相关论文
共 50 条
  • [1] Molecular dynamics Simulations of the catalytic pathway of a cysteine protease: A combined QM/MM study of human cathepsin K
    Ma, Shuhua
    Devi-Kesavan, Lakshmi S.
    Gao, Jiali
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (44) : 13633 - 13645
  • [2] QM/MM Molecular Dynamics Simulations Revealed Catalytic Mechanism of Urease
    Saito, Toru
    Takano, Yu
    JOURNAL OF PHYSICAL CHEMISTRY B, 2022, 126 (10): : 2087 - 2097
  • [3] Unraveling the concerted catalytic mechanism of the human immunodeficiency virus type 1 (HIV-1) protease: a hybrid QM/MM study
    Monsurat M. Lawal
    Zainab K. Sanusi
    Thavendran Govender
    Gideon F. Tolufashe
    Glenn E. M. Maguire
    Bahareh Honarparvar
    Hendrik G. Kruger
    Structural Chemistry, 2019, 30 : 409 - 417
  • [4] Unraveling the concerted catalytic mechanism of the human immunodeficiency virus type 1 (HIV-1) protease: a hybrid QM/MM study
    Lawal, Monsurat M.
    Sanusi, Zainab K.
    Govender, Thavendran
    Tolufashe, Gideon F.
    Maguire, Glenn E. M.
    Honarparvar, Bahareh
    Kruger, Hendrik G.
    STRUCTURAL CHEMISTRY, 2019, 30 (01) : 409 - 417
  • [5] Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia
    Chan, Chi-Ping
    Kok, Kin-Hang
    Jin, Dong-Yan
    INFECTIOUS AGENTS ASSOCIATED CANCERS: EPIDEMIOLOGY AND MOLECULAR BIOLOGY, 2017, 1018 : 147 - 166
  • [6] Efficient expression and rapid purification of human T-cell leukemia virus type 1 protease
    Ding, YS
    Owen, SM
    Lal, RB
    Ikeda, RA
    JOURNAL OF VIROLOGY, 1998, 72 (04) : 3383 - 3386
  • [7] The protease of human T-cell leukemia virus type-1 is a potential therapeutic target
    Tozser, Jozsef
    Weber, Irene T.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (12) : 1285 - 1294
  • [8] Substrates and inhibitors of human T-cell leukemia virus type I protease
    Ding, YS
    Rich, DH
    Ikeda, RA
    BIOCHEMISTRY, 1998, 37 (50) : 17514 - 17518
  • [9] T-Cell Control by Human T-Cell Leukemia/Lymphoma Virus Type 1
    Genoveffa Franchini
    Risaku Fukumoto
    Jake R. Fullen
    International Journal of Hematology, 2003, 78 : 280 - 296
  • [10] T-Cell control by human T-Cell leukemia/lymphoma virus type 1
    Franchini, G
    Fukumoto, R
    Fullen, JR
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) : 280 - 296